Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: Prostate. 2013 Dec 27;74(5):509–519. doi: 10.1002/pros.22770

Fig. 2.

Fig. 2

KaplanˆMeier survival analysis demonstrate significantly longer metastasis free survival in patients with high SPDEF. TMA was assembled from consecutive RP specimens of CaP patients at RPCI treated with the standard of care (n = 713). Cores IHC stained in triplicate with a-SPDEF and given a score on a1ˆ5 scale based on intensity. Metastasis disease defined as distant metastasis to lymph or organ sites. A median of 105 months follow-up was available for analysis. Analysis performed with SAS. A: Kaplan survival analysis. B: Numerical representation of patients and events analyzed at each time point.